Maternal-fetal Medicine
Guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids.
4 Nov, 2022 | 13:44h | UTCExecutive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids – Rheumatology
Cohort Study | Association of maternal caffeine consumption during pregnancy with child growth.
3 Nov, 2022 | 13:51h | UTCAssociation of Maternal Caffeine Consumption During Pregnancy With Child Growth – JAMA Network Open
Commentaries:
Expert reaction to study looking at caffeine in pregnancy and child height – Science Media Centre
Even a Little Coffee in Pregnancy Might Stunt a Child’s Growth – HealthDay
Related:
Cohort Study: Associations of Maternal Caffeine Intake with Birth Outcomes
Development, validation and clinical utility of a risk prediction model for adverse pregnancy outcomes in gestational diabetes.
3 Nov, 2022 | 13:45h | UTC
Commentary on Twitter (thread – click for more)
🧵PeRSonal GDM is a modelling tool that predicts if women with gestational diabetes could have ⬆️ risk of adverse pregnancy outcomes. It's being tested in other groups & developed as an online clinical calculator. New work by @DrShamilCooray @HelenaTeede & team in @eClinicalMed pic.twitter.com/tIyM4KHlre
— MCHRI (@MCHRImonash) September 5, 2022
Cohort Study | Pre-eclampsia is associated with increased risk of premature-onset obstructive coronary artery stenosis.
1 Nov, 2022 | 12:02h | UTCSeverity of obstructive coronary artery stenosis after pre-eclampsia – Heart
Related:
AHA Scientific Statement | Adverse Pregnancy Outcomes and Cardiovascular Disease Risk
Cohort Study: Preeclampsia and Cardiovascular Disease
All Hypertensive Disorders of Pregnancy Increase the Risk of Future Cardiovascular Disease
Gestational Hypertension and Future Risk of Cardiovascular Disease
RCT | A multicomponent intervention at preconception, pregnancy, and early childhood can improve child health at 24 months.
1 Nov, 2022 | 11:51h | UTC
Commentary on Twitter
Study shows a package of health, nutrition, psychosocial care, and water, sanitation and hygiene interventions delivered during preconception, pregnancy, and early childhood reduces the risk of low birth weight and stunting at 24 months of agehttps://t.co/VyzGprkAFH @CHRDSAS
— The BMJ (@bmj_latest) October 28, 2022
SR | Immediate versus delayed postpartum insertion of contraceptive implant and IUD for contraception.
31 Oct, 2022 | 13:56h | UTC
Systematic Review | Support for healthy breastfeeding mothers with healthy term babies.
28 Oct, 2022 | 13:23h | UTCSupport for healthy breastfeeding mothers with healthy term babies – Cochrane Library
Summary: Support for breastfeeding mothers – Cochrane Library
Cohort Study | Maternal hypertensive disorder of pregnancy and mortality in offspring from birth to young adulthood.
27 Oct, 2022 | 12:31h | UTCNews Release: Blood pressure disorder in pregnancy linked to heightened risk of death in offspring – BMJ Newsroom
Commentary on Twitter
NEW research: Maternal HDP, particularly eclampsia and severe pre-eclampsia, is associated with increased risks of overall mortality and various cause specific mortalities in offspring from birth to young adulthood https://t.co/kfczWFwzG5
— The BMJ (@bmj_latest) October 23, 2022
RCT | Effect of pentaerythritol tetranitrate (PETN) in pregnancies with impaired uteroplacental perfusion at midgestation.
24 Oct, 2022 | 14:05h | UTC
Commentary on Twitter
Effect of Pentaerythrityltetranitrate (PETN) on the development of fetal growth restriction in pregnancies with impaired uteroplacental perfusion at mid gestation – a randomised trial https://t.co/FJ3B7xV4sA pic.twitter.com/t32ij2Tssw
— AJOG (@AJOG_thegray) August 3, 2022
ACC/AHA blood pressure categories – A systematic review of the relationship with adverse pregnancy outcomes.
21 Oct, 2022 | 13:05h | UTC
Commentary on Twitter
American College of Cardiology/American Heart Association blood pressure categories – a systematic review of the relationship with adverse pregnancy outcomes https://t.co/8YbeVAysXS @acog @RCObsGyn @MySMFM @ranzcog pic.twitter.com/DiOKsihXWW
— AJOG (@AJOG_thegray) October 12, 2022
RCT | Effect of financial voucher incentives on the cessation of smoking in pregnant women.
21 Oct, 2022 | 12:58h | UTCEditorial: Financial incentives for sustained smoking abstinence in pregnancy – The BMJ
News Release: Shopping vouchers help women to stop smoking during pregnancy – BMJ Newsroom
Commentary on Twitter (thread – click for more)
Appreciate there are other things going on but …
Results from our phase III trial of financial incentives for smoking cessation in pregnancy published today in @bmj_latest 🧵1/3https://t.co/1El3JFSOQu— Linda Bauld (@LindaBauld) October 20, 2022
RCT | Moderate vs. intensive pushing during the active phase of the 2nd stage of labor among nulliparous women with an epidural.
18 Oct, 2022 | 12:56h | UTCAlternative to intensive management of the active phase of the second stage of labor: a multicenter randomized trial (Phase Active du Second STade trial) among nulliparous women with an epidural – American Journal of Obstetrics & Gynecology (link to abstract – $ for full-text)
Commentary on Twitter
Alternative to intensive management of the active phase of the second stage of labor: a multicenter randomized trial (PASST trial) among nulliparous women with an epidural – A, Intervention (moderate pushing) group. B, Control (intensive pushing) group. https://t.co/IfdNfWHo57 pic.twitter.com/KmZTYV8eIP
— AJOG (@AJOG_thegray) October 14, 2022
Special Statement | Postpartum visit checklists for normal pregnancy and complicated pregnancy.
14 Oct, 2022 | 14:18h | UTCOriginal Guideline: ACOG Postpartum Toolkit (PDF)
RCT | The substitution of biomass for gas cookstoves in pregnant women’s households did not improve infants’ birth weight.
13 Oct, 2022 | 13:52h | UTCLiquefied Petroleum Gas or Biomass for Cooking and Effects on Birth Weight – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries:
LPG for cooking didn’t improve weight of newborns, finds study – The Times of India
Benefits and risks associated with continuation of anti–TNF after 24 weeks of pregnancy in inflammatory bowel disease.
12 Oct, 2022 | 13:52h | UTCBenefits and Risks Associated With Continuation of Anti–Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentary: Continuation of Anti-TNF for IBD After 24 Weeks of Pregnancy Beneficial – HealthDay
Commentary on Twitter
10 year trial found continuation of #AntiTNF treatment after 24 weeks of pregnancy appears beneficial for #IBD activity and prematurity, not affecting neonatal outcomes and serious infections in the offspring. @EPIPHARE https://t.co/YuytSQqDsE pic.twitter.com/CRGN80K93A
— Annals of Int Med (@AnnalsofIM) September 27, 2022
M-A | Perinatal outcomes in pregnancies complicated by maternal cardiomyopathy.
11 Oct, 2022 | 13:24h | UTC
RCT | Intrapartum extended-release nifedipine to prevent severe intrapartum hypertension in patients with severe preeclampsia.
4 Oct, 2022 | 14:37h | UTCTrial of Intrapartum Extended-Release Nifedipine to Prevent Severe Hypertension Among Pregnant Individuals With Preeclampsia With Severe Features – Hypertension (link to abstract – $ for full-text)
News Release: Severe preeclampsia treated safely with nifedipine during labor and delivery – American Heart Association
Brief Review | Pregnancy-related acute kidney injury: do we know what to do?
3 Oct, 2022 | 13:54h | UTCPregnancy-Related Acute Kidney Injury: Do We Know What to Do? – Nephron
European Crohn’s and Colitis Guidelines on sexuality, fertility, pregnancy, and lactation.
29 Sep, 2022 | 13:30h | UTC
M-A | Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period.
28 Sep, 2022 | 13:47h | UTCCommentary: Risk factors among pregnant and postpartum women with COVID-19 – News Medical
ESC Scientific Statement | Sex differences in arterial hypertension.
26 Sep, 2022 | 12:10h | UTC
Commentary on Twitter
Terrific work on this important statement on #sexdifferences in #hypertension @EvaGerdts @AnastasiaSMihai @MaasAngela et al! 👏🏽https://t.co/jhTXP0NTqJ pic.twitter.com/VBkbKLyV5K
— Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦 (@DrMarthaGulati) September 23, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ license
M-A | Association of gestational diabetes mellitus with cardiovascular and cerebrovascular diseases.
26 Sep, 2022 | 12:01h | UTCNews Release: Diabetes in pregnancy linked to risk of cardiovascular and cerebrovascular disease – BMJ Newsroom
Commentary on Twitter
Gestational diabetes mellitus is associated with increased risks of overall and type specific cardiovascular and cerebrovascular diseases that cannot be solely attributed to conventional cardiovascular risk factors or subsequent diabetes, finds new studyhttps://t.co/0fCIXKVK99
— The BMJ (@bmj_latest) September 22, 2022
USPSTF Draft Statement | Screening for depression is recommended in the adult population.
23 Sep, 2022 | 13:16h | UTCScreening for Depression and Suicide Risk in Adults – U.S. Preventive Services Task Force
USPSTF Draft Statement | Screening for anxiety and depression in adults is recommended.
23 Sep, 2022 | 13:15h | UTCScreening for Anxiety in Adults – U.S. Preventive Services Task Force
M-A of randomized trials | Ondansetron vs. Metoclopramide for managing hyperemesis gravidarum.
19 Sep, 2022 | 12:34h | UTCCommentary: Ondansetron or metoclopramide, which is better for managing hyperemesis gravidarum? – Medical Dialogues


